This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Ucb Pharma Gmbh. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: The Innovative Contributions of Sanjay Bhattarai
Introduction
Sanjay Bhattarai is a notable inventor based in Lawrence, KS (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Sanjay holds 3 patents, with his latest inventions focusing on Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides. These patents disclose sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases. In particular, these compounds show promise in preventing and treating myelinating diseases or disorders.
Career Highlights
Sanjay is currently employed at UCB Pharma GmbH, where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Some of his notable coworkers include Christa E Mueller and Cécile Pegurier, with whom he collaborates on various projects within the company.
Conclusion
Sanjay Bhattarai's work exemplifies the spirit of innovation in the pharmaceutical field, and his contributions are paving the way for new treatments for complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile